Legal & General Group PLC Essa Pharma Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$3.15 - $7.94 $19,290 - $48,624	-6,124 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.8 - $14.38 $7,823 - $14,423	1,003 Added 19.59%	6,124 $87,000
Q3 2021 Nov 15, 2021	BUY	$7.76 - $29.37 $32,568 - $123,265	4,197 Added 454.22%	5,121 $41,000
Q2 2021 Aug 12, 2021	BUY	$24.17 - $34.28 $22,333 - $31,674	924 New	924 $26,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.